Nouscom raises €120m for cancer immunotherapy
Nouscom has closed a €120m round for its cancer immunotherapy pipeline, with Angelini Ventures and M Ventures among the named backers, Global Venturing reports.
Topic
M Ventures
Topic
Topic
Topic
Nouscom has closed a €120m round for its cancer immunotherapy pipeline, with Angelini Ventures and M Ventures among the named backers, Global Venturing reports.